Engineers Gate Manager LP grew its holdings in Owens & Minor (NYSE:OMI) by 155.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 124,807 shares of the company’s stock after buying an additional 75,868 shares during the quarter. Engineers Gate Manager LP owned approximately 0.20% of Owens & Minor worth $1,941,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Alps Advisors Inc. acquired a new stake in shares of Owens & Minor in the fourth quarter valued at $466,000. Opus Capital Group LLC acquired a new stake in shares of Owens & Minor in the fourth quarter valued at $2,937,000. SG Americas Securities LLC increased its stake in shares of Owens & Minor by 12.3% in the fourth quarter. SG Americas Securities LLC now owns 134,397 shares of the company’s stock valued at $2,537,000 after buying an additional 14,694 shares in the last quarter. Aperio Group LLC increased its stake in shares of Owens & Minor by 17.0% in the fourth quarter. Aperio Group LLC now owns 67,402 shares of the company’s stock valued at $1,273,000 after buying an additional 9,814 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its stake in shares of Owens & Minor by 11.8% in the fourth quarter. UBS Asset Management Americas Inc. now owns 61,941 shares of the company’s stock valued at $1,169,000 after buying an additional 6,560 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.
OMI has been the subject of a number of research reports. JPMorgan Chase lowered their target price on Owens & Minor from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Thursday, February 15th. ValuEngine lowered Owens & Minor from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research lowered Owens & Minor from a “hold” rating to a “sell” rating in a research report on Wednesday, January 24th. Bank of America assumed coverage on Owens & Minor in a research report on Tuesday, February 27th. They issued a “buy” rating and a $19.00 price objective for the company. Finally, Barclays assumed coverage on Owens & Minor in a research report on Thursday, March 8th. They issued an “underweight” rating and a $16.00 price objective for the company. Six analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $24.28.
Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Thursday, May 10th. The company reported $0.43 EPS for the quarter, missing the Zacks’ consensus estimate of $0.47 by ($0.04). The firm had revenue of $2.37 billion during the quarter, compared to analyst estimates of $2.39 billion. Owens & Minor had a return on equity of 9.65% and a net margin of 0.66%. Owens & Minor’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.44 earnings per share. equities analysts anticipate that Owens & Minor will post 2 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, July 2nd. Stockholders of record on Friday, June 15th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Thursday, June 14th. This represents a $1.04 annualized dividend and a dividend yield of 6.15%. Owens & Minor’s payout ratio is currently 64.60%.
Owens & Minor Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.